Aurobindo Q3 net rises 6% to Rs 578 cr

The total income of the company increased 11% to Rs 3,906 cr

Aurobindo Pharma has reported 6.3 per cent growth in net profit at Rs 578.59 crore in third quarter (Q3) of FY 2017, against Rs 544.31 crore during same period previous fiscal. The total income of the company increased 11.4 per cent to Rs 3,906.18 crore in the quarter under review from Rs 3,505.60 crore during the corresponding previous quarter.

"Despite pricing pressure in select products, we have recorded a good overall growth in Q3 of FY 17 due to diversified product basket and markets. We remain focused on developing a differentiated and speciality product basket which will drive our future growth,"